EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY 4.0

Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review

Julia Habryka, Maja Ławniczek, Sabina Krupa-Nurcek iD

Nutrients · 26.06.2026 · 18 (13) · 2093

DOI: 10.3390/nu18132093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 26.06.2026. Verfasst von Julia Habryka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland. Hauptthemen laut MEDLINE: Inositol, Polycystic Ovary Syndrome, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Polycystic ovary syndrome (PCOS) is a widespread and complex endocrine disorder affecting women of childbearing potential, characterized by reproductive dysfunction, hyperandrogenism, and metabolic disorders, including insulin resistance. Insulin resistance is a key pathogenetic factor contributing to ovarian dysfunction and reduced fertility. Myo-inositol (MI), a ubiquitous polyol, has earned a reputation as a promising dietary supplement due to its vital role in insulin signaling pathways. This scoping review aimed to map the available scientific literature on the effects of MI supplementation in women with PCOS, with particular emphasis on fertility and ovarian function, and to identify gaps in the current evidence base.

Methods

This scoping review was conducted in accordance with the methodology developed by the Joanna Briggs Institute (JBI) and presented in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) guidelines. A literature search was conducted against six electronic databases: PubMed, Scopus, Web of Science, EBSCO (MEDLINE Complete), Cochrane Library and Google Scholar. Searches were conducted between 10 January and 20 February 2026. Eligibility sources included original articles (observational and randomized controlled trials), meta-analyses, systematic and narrative reviews, published in English with full text available, focusing on adult women with PCOS. Data extraction was performed independently by two reviewers using the Population–Concept–Context (PCC) framework. In accordance with the scope review methodology, no formal critical appraisal of study quality and no quantitative synthesis were performed. This is consistent with JBI methodology, which does not require critical appraisal for scoping reviews unless explicitly justified.

Results

Of the 77 records initially identified, 13 studies were included in the review, and no duplicates were found. These potential benefits should be interpreted cautiously, as the available evidence is heterogeneous and varies across study designs. Potential benefits were also reported for hormonal and metabolic parameters, including reductions in hyperandrogenism and the improvement of insulin sensitivity. Some studies suggest benefits for oocyte and embryo quality, but results remain inconsistent.

Conclusions

MI supplementation may support PCOS management, particularly in fertility-related outcomes. Its ability to improve ovulation, increase pregnancy rates, optimize ART outcomes, and mitigate the risk of OHSS highlights its clinical utility. However, the evidence remains heterogeneous, and some outcomes, particularly oocyte and embryo quality, remain inconclusive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InositolPolycystic Ovary SyndromeDietary SupplementsHumansFemaleFertilityInsulin ResistancePregnancyAdultInfertility, FemaleOvary

Stichwörter der Autor:innen

ARTPCOSmyo-inositolovarian functionovulationpolycystic ovary syndrome

Substanzen

Inositol

Autor:innen und Institutionen

  • Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.
  • Department of Surgery, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.

ORCID-Profile: Sabina Krupa-Nurcek

Zitieren

APA

Habryka, J., Ławniczek, M., & Krupa-Nurcek, S. (2026). Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review. Nutrients, 18(13), 2093. https://doi.org/10.3390/nu18132093

Vancouver

Habryka J, Ławniczek M, Krupa-Nurcek S. Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review. Nutrients. 2026;18(13):2093. doi:10.3390/nu18132093

BibTeX
@article{Habryka2026,
  author = {Habryka, Julia and Ławniczek, Maja and Krupa-Nurcek, Sabina},
  title = {Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2093},
  doi = {10.3390/nu18132093}
}
Kostenlos starten →